The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.521
https://www.valueinhealthjournal.com/article/S1098-3015(14)02451-6/fulltext
Title :
The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02451-6&doi=10.1016/j.jval.2014.08.521
First page :
A806
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
2513